| Income Statement |
| Total Revenue | 192.12M |
|
| Revenues (USD) | 192.12M |
| Cost of Revenue | 59.22M |
| Gross Profit | 132.90M |
| Operating Expenses | 108.35M |
| Research and Development Expense | 17.92M |
| Selling, General and Administrative Expense | 81.11M |
| Operating Income | 24.56M |
| Income Tax Expense | 6.24M |
| Net Income | 19.73M |
| Net Income Common Stock | 19.73M |
| Net Income Common Stock (USD) | 19.73M |
| Consolidated Income | 19.73M |
| Earnings per Basic Share | 0.53 |
| Earnings per Basic Share (USD) | 0.53 |
| Earnings per Diluted Share | 0.53 |
| Earning Before Interest & Taxes (EBIT) | 25.96M |
| Earning Before Interest & Taxes (USD) | 25.96M |
| Weighted Average Shares | 37.38M |
| Weighted Average Shares Diluted | 37.44M |
| Balance Sheet |
| Cash and Equivalents | 154.27M |
| Cash and Equivalents (USD) | 154.27M |
| Trade and Non-Trade Receivables | 65.11M |
| Current Assets | 328.74M |
| Property, Plant & Equipment Net | 51.01M |
| Total Assets | 1.16B |
| Debt Current | 1.92M |
| Total Debt | 6.62M |
| Current Liabilities | 154.95M |
| Debt Non-Current | 4.70M |
| Total Liabilities | 199.05M |
| Accumulated Retained Earnings (Deficit) | 449.17M |
| Accumulated Other Comprehensive Income | -1.69M |
| Shareholders Equity | 962.16M |
| Shareholders Equity (USD) | 962.16M |
| Assets Non-Current | 832.47M |
| Total Debt (USD) | 6.62M |
| Deferred Revenue | 85.70M |
| Goodwill and Intangible Assets | 746.91M |
| Liabilities Non-Current | 44.10M |
| Trade and Non-Trade Payables | 14.47M |
| Tax Assets | 511.00K |
| Tax Liabilities | 33.80M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 15.15M |
| Net Cash Flow from Financing | -45.86M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.92M |
| Capital Expenditure | -7.14M |
| Issuance (Purchase) of Equity Shares | -45.86M |
| Net Cash Flow from Investing | -7.14M |
| Net Cash Flow from Operations | 55.63M |
| Effect of Exchange Rate Changes on Cash | 288.00K |
| Share Based Compensation | 18.07M |